The global market for adult clinical oral nutrition has been growing rapidly in recent years, driven by an increasing aging population and rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders. Oral nutritional supplements (ONS) play a crucial role in maintaining the nutritional status of elderly and critically ill patients, who are often at a higher risk of malnutrition due to their condition or treatment. With the growing demand for personalized nutrition and functional foods, the market is also witnessing the emergence of innovative ONS products that offer targeted health benefits beyond basic nutrition.
Market Trends and Drivers: The global adult clinical oral nutrition market is expected to continue its growth trajectory in the coming years, with a projected CAGR of over 7% from 2021 to 2026. One of the major drivers of the market is the increasing aging population, which is expected to reach 1.5 billion by 2050, according to the United Nations. The prevalence of chronic diseases is also on the rise, with cancer, diabetes, and cardiovascular diseases being the leading causes of death worldwide. In addition, there is a growing awareness about the importance of nutritional therapy in disease management, which has led to increased adoption of ONS by healthcare providers.
Another trend shaping the market is the growing demand for personalized nutrition and functional foods, which has led to the development of tailored ONS products for specific conditions such as cancer cachexia, sarcopenia, and malabsorption. These products contain targeted ingredients such as omega-3 fatty acids, antioxidants, and probiotics that offer health benefits beyond basic nutrition. Companies are also investing in research and development of novel ingredients and formulations that can improve the efficacy and safety of ONS products.
Challenges and Restraints: Despite the positive growth outlook, the adult clinical oral nutrition market faces certain challenges and restraints that could hinder its progress. One of the major challenges is the high cost of ONS products, which may limit their accessibility to low-income populations. In addition, there is a lack of standardization in the labeling and regulation of ONS products, which can lead to confusion and misinterpretation by consumers and healthcare providers. Moreover, the increasing competition from alternative forms of nutritional therapy such as enteral and parenteral nutrition may pose a threat to the growth of the ONS market.
Key Players and Competitive Landscape: The global adult clinical oral nutrition market is highly competitive, with several players operating in the space. Some of the key players in the market include Nestle Health Science, Abbott Laboratories, Danone Nutricia, Baxter International Inc., and B. Braun Melsungen AG. These companies are investing in research and development of innovative products, partnerships, and collaborations to expand their market presence and customer base. They are also focusing on marketing and promotional activities to increase awareness and adoption of their products.
Emerging Trends and Opportunities: The adult clinical oral nutrition market is expected to offer several emerging trends and opportunities in the coming years. One of the emerging trends is the use of digital technologies such as mobile apps and wearable devices to monitor and track the nutritional status of patients. These technologies can provide real-time data on patients’ food intake, energy expenditure, and weight changes, which can help healthcare providers to personalize the nutrition therapy and optimize its outcomes. Another emerging trend is the integration of artificial intelligence and machine learning algorithms in ONS products to improve their efficacy and safety.
Conclusion: The global adult clinical oral nutrition market is poised for significant growth in the coming years, driven by the increasing aging population, rising prevalence of chronic diseases, and growing demand for personalized nutrition and functional foods. The market is witnessing the emergence of innovative ONS products that offer targeted health benefits beyond basic nutrition, and companies are investing in research and development
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Market Insight Lab journalist was involved in the writing and production of this article.
